{
  "nctId": "NCT02880189",
  "briefTitle": "EUS Guided Core Liver Biopsy and IGB Placement for the Diagnosis and Management of NASH and Obesity",
  "officialTitle": "Combined Endoscopic Ultrasound Guided Core Liver Biopsy and Intragastric Balloon Placement for the Diagnosis and Management of Nonalcoholic Steatohepatitis and Obesity",
  "protocolDocument": {
    "nctId": "NCT02880189",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2017-06-23",
    "uploadDate": "2019-03-18T14:14",
    "size": 456309,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02880189/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 21,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-12",
    "completionDate": "2018-03-13",
    "primaryCompletionDate": "2018-03-13",
    "firstSubmitDate": "2016-08-23",
    "firstPostDate": "2016-08-26"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients diagnosed with Non-alcoholic Steatohepatitis with early evidence of fibrosis as seen on MRE-hepatogram\n* Referred clinically for an intragastric balloon placement for weight loss\n\nExclusion Criteria:\n\n* Women who are pregnant or plan to be pregnant or are breastfeeding\n* Previous history of gastric surgery\n* Current or recent (within 6 months) gastric or duodenal ulcers\n* Gastroparesis\n* Liver cirrhosis\n* Coagulopathy or active use of coagulation\n* Inability to provide a written informed consent",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "22 Years",
    "maximumAge": "69 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Weight Loss Achieved With Intragastric Balloon (IGB)",
        "description": "Total number of subjects with two points or greater improvement on objective Non-alcoholic Steatohepatitis (NASH) histopathological parameters. The NAS scale can range from 0 to 8 and is calculated by the sum of scores of steatosis (0-3), lobular inflammation (0-3) and hepatocyte ballooning (0-2).",
        "timeFrame": "Baseline to 6 months post-procedure"
      }
    ],
    "secondary": [
      {
        "measure": "Diagnosis of NASH and Early Fibrosis by Endoscopic Ultrasound (EUS) Guided Liver Core Biopsies",
        "description": "Total number of subjects correctly diagnosed with NASH and Early Fibrosis by EUS guided core liver biopsies",
        "timeFrame": "Baseline to 6 months post-procedure"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 19,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:30:16.678Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}